Cite
HARVARD Citation
Sarsenbayeva, G. et al. (2020). Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan. Human vaccines & immunotherapeutics. 16 (8), pp. 1791-1797. [Online].